TRADING ALERT: Hollister Biosciences (HOLL:CSE) (HSTRF: OTC) Up 19% On 1M Shares
posted on
Jan 13, 2021 01:02PM
Q4 2020 Performance Includes CDN $14.93 Million in Revenue With an Estimated CDN $5.53 Million in EBITDA a YoY Revenue Increase of 3215% from Q4 2019